Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04374305
Title Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Scott R. Plotkin, MD, PhD
Indications

low grade glioma

neurilemmoma

meningioma

benign ependymoma

neurofibroma

acoustic neuroma

Therapies

Brigatinib

Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.